{"url_path":"/sec/idxg/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1054102/0001493152-26-022508-index.html","accession_number":"0001493152-26-022508","cik":"0001054102","ticker":"IDXG","issuer_name":"INTERPACE BIOSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1054102/0001493152-26-022508-index.html","primary_entity_key":"0001054102","primary_entity_name":"INTERPACE BIOSCIENCES, INC."},"word_count":97,"has_tables":true,"body_markdown":"**Item\n1A. Risk Factors**\n\n \n\nIn\naddition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, “Risk\nFactors” in our Annual Report on Form 10-K of the Company filed with the SEC on March 30, 2026, as amended, and as updated and\nsupplemented in subsequent filings. These risk factors could materially harm our business, operating results and financial condition.\nAdditional factors and uncertainties not currently known to us or that we currently consider immaterial also may materially adversely\naffect our business, financial condition or future results."}